Managed Healthcare Executive provides C-suite executives at health plans and provider organizations with news, analysis, ...

The data include an interim look at the dose-escalation portion of a phase 2 trial assessing the adenosine A2A receptor ...

Lung cancer is the third most common cancer and the leading cause of cancer-related deaths in the U.S., and according to the American Lung Association, the rate of new lung ...

BNT327, now in early-phase trials, is part of a class of drugs that could one day challenge Keytruda’s dominance. BioNTech ...

Hailed as a savior, Dr. Thomas C. Weiner became a patient favorite and his hospital’s highest earner. As the myth surrounding ...

It’s claimed cancer patients in Clare are routinely subjected to undignified and inhumane conditions due to a lack of local ...

Experts discussed what other information is needed to understand how best to use Kisqali in treating patients in the adjuvant ...

These two new medical mobile units at CAMC are additions to the fleet that Vandalia Health and CAMC have been acquiring since ...

The Food and Drug Administration (FDA) has approved Imfinzi ® (durvalumab), as a single agent, for the treatment of adult patients with limited-stage small cell lung cancer (LS-SCLC) whose disease has ...

About Zetagen Therapeutics Founded in 2015, Zetagen Therapeutics is a private, clinical-stage, biopharmaceutical company ...

The American Lung Association released its 2024 State of Lung Cancer report, which examines key indicators to highlight how the toll of lung cancer varies by state. Lung cancer is the leading cause of ...